nach oben

Current Diabetes Reports

Erschienen in:

01.07.2020 | Obesity (KM Gadde and P Singh, Section Editors)

CNS Regulation of Glucose Homeostasis: Role of the Leptin-Melanocortin System

verfasst von: Alexandre A. da Silva, Jussara M. do Carmo, John E. Hall

Erschienen in: Current Diabetes Reports | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

In this brief review, we highlight studies that have contributed to our current understanding of glucose homeostasis by the central nervous system (CNS) leptin-melanocortin system, particularly proopiomelanocortin neurons and melanocortin-4 receptors (MC4R).

Recent Findings

Leptin deficiency is associated with insulin resistance and impaired glucose metabolism whereas leptin administration improves tissue glucose uptake/oxidation and reduces hepatic glucose output. These antidiabetic effects of leptin have been demonstrated in experimental animals and humans, even when circulating insulin levels are barely detectable. Recent evidence suggests that these antidiabetic actions of leptin are mediated, in large part, by stimulation of leptin receptors (LRs) in the CNS and require activation of proopiomelanocortin (POMC) neurons and MC4R. These chronic antidiabetic effects of the CNS leptin-melanocortin system appear to be independent of autonomic nervous system and pituitary-thyroid-adrenal (PTA) axis mechanisms.

Summary

The powerful antidiabetic actions of the CNS leptin-melanocortin system are capable of normalizing plasma glucose even in the absence of insulin and involve interactions of multiple neuronal populations and intracellular signaling pathways. Although the links between the CNS leptin-melanocortin system and its chronic effects on peripheral tissue glucose metabolism are still uncertain, they are independent of insulin action, activation of the autonomic nervous system, or the PTA axis. Unraveling the pathways that contribute to the powerful antidiabetic effects of the CNS leptin-melanocortin system may provide novel therapeutic approaches for diabetes mellitus.

Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature. 1997;389(6649):374–7. https://doi.org/10.1038/38717.CrossRefPubMed

Chinookoswong N, Wang JL, Shi ZQ. Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat. Diabetes. 1999;48(7):1487–92. https://doi.org/10.2337/diabetes.48.7.1487.CrossRefPubMed

Friedman J. The long road to leptin. J Clin Invest. 2016;126(12):4727–34. https://doi.org/10.1172/JCI91578.CrossRefPubMedPubMedCentral

Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425–32. https://doi.org/10.1038/372425a0.CrossRefPubMed

Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, et al. Effects of the obese gene product on body weight regulation in Ob/Ob mice. Science. 1995;269(5223):540–3. https://doi.org/10.1126/science.7624776.CrossRefPubMed

Barzilai N, Wang J, Massilon D, Vuguin P, Hawkins M, Rossetti L. Leptin selectively decreases visceral adiposity and enhances insulin action. J Clin Invest. 1997;100(12):3105–10. https://doi.org/10.1172/JCI119865.CrossRefPubMedPubMedCentral

Yaspelkis BB 3rd, Ansari L, Ramey EL, Holland GJ, Loy SF. Chronic leptin administration increases insulin-stimulated skeletal muscle glucose uptake and transport. Metabolism. 1999;48(5):671–6. https://doi.org/10.1016/s0026-0495(99)90070-7.CrossRefPubMed

Yaspelkis BB 3rd, Davis JR, Saberi M, Smith TL, Jazayeri R, Singh M, et al. Leptin administration improves skeletal muscle insulin responsiveness in diet-induced insulin-resistant rats. Am J Physiol Endocrinol Metab. 2001;280(1):E130–42. https://doi.org/10.1152/ajpendo.2001.280.1.E130.CrossRefPubMed

Lin CY, Higginbotham DA, Judd RL, White BD. Central leptin increases insulin sensitivity in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab. 2002;282(5):E1084–91. https://doi.org/10.1152/ajpendo.00489.2001.CrossRefPubMed

10.

Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension. 1998;31(1 Pt 2):409–14. https://doi.org/10.1161/01.hyp.31.1.409.CrossRefPubMed

11.

Yu X, Park BH, Wang MY, Wang ZV, Unger RH. Making insulin-deficient type 1 diabetic rodents thrive without insulin. Proc Natl Acad Sci U S A. 2008;105(37):14070–5. https://doi.org/10.1073/pnas.0806993105.CrossRefPubMedPubMedCentral

12.

Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med. 2002;346(8):570–8. https://doi.org/10.1056/NEJMoa012437.CrossRefPubMed

13.

Petersen KF, Oral EA, Dufour S, Befroy D, Ariyan C, Yu C, et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest. 2002;109(10):1345–50. https://doi.org/10.1172/JCI15001.CrossRefPubMedPubMedCentral

14.

Park JY, Chong AY, Cochran EK, Kleiner DE, Haller MJ, Schatz DA, et al. Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: the effect of long-term leptin therapy. J Clin Endocrinol Metab. 2008;93(1):26–31. https://doi.org/10.1210/jc.2007-1856.CrossRefPubMed

15.

Ebihara K, Kusakabe T, Hirata M, Masuzaki H, Miyanaga F, Kobayashi N, et al. Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy. J Clin Endocrinol Metab. 2007;92(2):532–41. https://doi.org/10.1210/jc.2006-1546.CrossRefPubMed

16.

Haap M, Houdali B, Maerker E, Renn W, Machicao F, Hoffmeister HM, et al. Insulin-like effect of low-dose leptin on glucose transport in Langendorff rat hearts. Exp Clin Endocrinol Diabetes. 2003;111(3):139–45. https://doi.org/10.1055/s-2003-39786.CrossRefPubMed

17.

Minokoshi Y, Haque MS, Shimazu T. Microinjection of leptin into the ventromedial hypothalamus increases glucose uptake in peripheral tissues in rats. Diabetes. 1999;48(2):287–91. https://doi.org/10.2337/diabetes.48.2.287.CrossRefPubMed

18.

Hidaka S, Yoshimatsu H, Kondou S, Tsuruta Y, Oka K, Noguchi H, et al. Chronic central leptin infusion restores hyperglycemia independent of food intake and insulin level in streptozotocin-induced diabetic rats. FASEB J. 2002;16(6):509–18. https://doi.org/10.1096/fj.01-0164com.CrossRefPubMed

19.

da Silva AA, Tallam LS, Liu J, Hall JE. Chronic antidiabetic and cardiovascular actions of leptin: role of CNS and increased adrenergic activity. Am J Phys Regul Integr Comp Phys. 2006;291(5):R1275–82. https://doi.org/10.1152/ajpregu.00187.2006.CrossRef

20.

do Carmo JM, da Silva AA, Gava FN, Moak SP, Dai X, Hall JE. Impact of leptin deficiency compared with neuronal-specific leptin receptor deletion on cardiometabolic regulation. Am J Phys Regul Integr Comp Phys. 2019;317(4):R552–R62. https://doi.org/10.1152/ajpregu.00077.2019.CrossRef

21.

Hall JE, da Silva AA, do Carmo JM, Dubinion J, Hamza S, Munusamy S, et al. Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J Biol Chem. 2010;285(23):17271–6. https://doi.org/10.1074/jbc.R110.113175.CrossRefPubMedPubMedCentral

22.

Dubinion JH, do Carmo JM, Adi A, Hamza S, da Silva AA, Hall JE. Role of proopiomelanocortin neuron Stat3 in regulating arterial pressure and mediating the chronic effects of leptin. Hypertension. 2013;61(5):1066–74. https://doi.org/10.1161/HYPERTENSIONAHA.111.00020.CrossRefPubMedPubMedCentral

23.

do Carmo JM, da Silva AA, Wang Z, Freeman NJ, Alsheik AJ, Adi A, et al. Regulation of blood pressure, appetite, and glucose by leptin after inactivation of insulin receptor substrate 2 signaling in the entire brain or in proopiomelanocortin neurons. Hypertension. 2016;67(2):378–86. https://doi.org/10.1161/HYPERTENSIONAHA.115.06153.CrossRefPubMed

24.

Sadagurski M, Leshan RL, Patterson C, Rozzo A, Kuznetsova A, Skorupski J, et al. IRS2 signaling in LepR-b neurons suppresses FoxO1 to control energy balance independently of leptin action. Cell Metab. 2012;15(5):703–12. https://doi.org/10.1016/j.cmet.2012.04.011.CrossRefPubMedPubMedCentral

25.

do Carmo JM, da Silva AA, Ebaady SE, Sessums PO, Abraham RS, Elmquist JK, et al. Shp2 signaling in POMC neurons is important for leptin's actions on blood pressure, energy balance, and glucose regulation. Am J Phys Regul Integr Comp Phys. 2014;307(12):R1438–47. https://doi.org/10.1152/ajpregu.00131.2014.CrossRef

26.

do Carmo JM, da Silva AA, Sessums PO, Ebaady SH, Pace BR, Rushing JS, et al. Role of Shp2 in forebrain neurons in regulating metabolic and cardiovascular functions and responses to leptin. Int J Obes. 2014;38(6):775–83. https://doi.org/10.1038/ijo.2013.177.CrossRef

27.

da Silva AA, do Carmo JM, Wang Z, Hall JE. Melanocortin-4 receptors and sympathetic nervous system activation in hypertension. Curr Hypertens Rep. 2019;21(6):46. https://doi.org/10.1007/s11906-019-0951-x.CrossRefPubMedPubMedCentral

28.

Baldini G, Phelan KD. The melanocortin pathway and control of appetite-progress and therapeutic implications. J Endocrinol. 2019;241(1):R1–R33. https://doi.org/10.1530/JOE-18-0596.CrossRefPubMedPubMedCentral

29.

Kuhnen P, Krude H, Biebermann H. Melanocortin-4 receptor Signalling: importance for weight regulation and obesity treatment. Trends Mol Med. 2019;25(2):136–48. https://doi.org/10.1016/j.molmed.2018.12.002.CrossRefPubMed

30.

Kuo JJ, Silva AA, Hall JE. Hypothalamic melanocortin receptors and chronic regulation of arterial pressure and renal function. Hypertension. 2003;41(3 Pt 2):768–74. https://doi.org/10.1161/01.HYP.0000048194.97428.1A.CrossRefPubMed

31.

Tallam LS, Kuo JJ, da Silva AA, Hall JE. Cardiovascular, renal, and metabolic responses to chronic central administration of agouti-related peptide. Hypertension. 2004;44(6):853–8. https://doi.org/10.1161/01.HYP.0000148993.47498.b2.CrossRefPubMed

32.

da Silva AA, Kuo JJ, Hall JE. Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin. Hypertension. 2004;43(6):1312–7. https://doi.org/10.1161/01.HYP.0000128421.23499.b9.CrossRefPubMed

33.

Tallam LS, Stec DE, Willis MA, da Silva AA, Hall JE. Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia. Hypertension. 2005;46(2):326–32. https://doi.org/10.1161/01.HYP.0000175474.99326.bf.CrossRefPubMed

34.

Stepp DW, Osakwe CC, Belin de Chantemele EJ, Mintz JD. Vascular effects of deletion of melanocortin-4 receptors in rats. Phys Rep. 2013;1(6):e00146. https://doi.org/10.1002/phy2.146.CrossRef

35.

da Silva AA, Spradley FT, Granger JP, Hall JE, do Carmo JM. Brain-mediated antidiabetic, anorexic, and cardiovascular actions of leptin require melanocortin-4 receptor signaling. J Neurophysiol. 2015;113(7):2786–91. https://doi.org/10.1152/jn.00911.2014.CrossRefPubMedPubMedCentral

36.

Obici S, Feng Z, Tan J, Liu L, Karkanias G, Rossetti L. Central melanocortin receptors regulate insulin action. J Clin Invest. 2001;108(7):1079–85. https://doi.org/10.1172/JCI12954.CrossRefPubMedPubMedCentral

37.

• Tooke BP, Yu H, Adams JM, Jones GL, Sutton-Kennedy T, Mundada L, et al. Hypothalamic POMC or MC4R deficiency impairs counterregulatory responses to hypoglycemia in mice. Mol Metab. 2019;20:194–204. https://doi.org/10.1016/j.molmet.2018.11.004. This study demonstrates that the brain melanocortin system, particularly POMC neurons and MC4R, is impootant for normal counterregulatory responses that attenuate the impact of hypoglycemia.

38.

Bassi M, Nakamura NB, Furuya WI, Colombari DS, Menani JV, do Carmo JM et al. Activation of the brain melanocortin system is required for leptin-induced modulation of chemorespiratory function. Acta Physiol (Oxford) 2015;213(4):893–901. https://doi.org/10.1111/apha.12394.

39.

Haynes WG, Morgan DA, Djalali A, Sivitz WI, Mark AL. Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension. 1999;33(1 Pt 2):542–7.CrossRefPubMed

40.

do Carmo JM, da Silva AA, Cai Z, Lin S, Dubinion JH, Hall JE. Control of blood pressure, appetite, and glucose by leptin in mice lacking leptin receptors in proopiomelanocortin neurons. Hypertension. 2011;57(5):918–26. https://doi.org/10.1161/HYPERTENSIONAHA.110.161349.CrossRefPubMedPubMedCentral

41.

Huo L, Gamber K, Greeley S, Silva J, Huntoon N, Leng XH, et al. Leptin-dependent control of glucose balance and locomotor activity by POMC neurons. Cell Metab. 2009;9(6):537–47. https://doi.org/10.1016/j.cmet.2009.05.003.CrossRefPubMedPubMedCentral

42.

Tallam LS, da Silva AA, Hall JE. Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin. Hypertension. 2006;48(1):58–64. https://doi.org/10.1161/01.HYP.0000227966.36744.d9.CrossRefPubMed

43.

da Silva AA, do Carmo JM, Freeman JN, Tallam LS, Hall JE. A functional melanocortin system may be required for chronic CNS-mediated antidiabetic and cardiovascular actions of leptin. Diabetes. 2009;58(8):1749–56. https://doi.org/10.2337/db08-1221.CrossRefPubMedPubMedCentral

44.

da Silva AA, Freeman JN, Hall JE, do Carmo JM. Control of appetite, blood glucose, and blood pressure during melanocortin-4 receptor activation in normoglycemic and diabetic NPY-deficient mice. Am J Phys Regul Integr Comp Phys. 2018;314(4):R533–R9. https://doi.org/10.1152/ajpregu.00293.2017.CrossRef

45.

• Fujikawa T, Berglund ED, Patel VR, Ramadori G, Vianna CR, Vong L, et al. Leptin engages a hypothalamic neurocircuitry to permit survival in the absence of insulin. Cell Metab. 2013;18(3):431–44. https://doi.org/10.1016/j.cmet.2013.08.004. This study shows that GABAergic neurons, in addition to POMC neurons, play a critical role in mediating the effects of leptin non-diabetic and insulin-deficient diabetic animals.

46.

Zhao S, Zhu Y, Schultz RD, Li N, He Z, Zhang Z, et al. Partial leptin reduction as an insulin sensitization and weight loss strategy. Cell Metab. 2019;30(4):706–19 e6. https://doi.org/10.1016/j.cmet.2019.08.005.CrossRefPubMed

47.

Marsh DJ, Miura GI, Yagaloff KA, Schwartz MW, Barsh GS, Palmiter RD. Effects of neuropeptide Y deficiency on hypothalamic agouti-related protein expression and responsiveness to melanocortin analogues. Brain Res. 1999;848(1–2):66–77. https://doi.org/10.1016/s0006-8993(99)01962-9.CrossRefPubMed

48.

Sindelar DK, Mystkowski P, Marsh DJ, Palmiter RD, Schwartz MW. Attenuation of diabetic hyperphagia in neuropeptide Y--deficient mice. Diabetes. 2002;51(3):778–83. https://doi.org/10.2337/diabetes.51.3.778.CrossRefPubMed

49.

Loh K, Herzog H, Shi YC. Regulation of energy homeostasis by the NPY system. Trends Endocrinol Metab. 2015;26(3):125–35. https://doi.org/10.1016/j.tem.2015.01.003.CrossRefPubMed

50.

Singha AK, Yamaguchi J, Gonzalez NS, Ahmed N, Toney GM, Fujikawa T. Glucose-lowering by leptin in the absence of insulin does not fully rely on the central melanocortin system in male mice. Endocrinology. 2019;160(3):651–63. https://doi.org/10.1210/en.2018-00907.CrossRefPubMedPubMedCentral

51.

German JP, Thaler JP, Wisse BE, Oh IS, Sarruf DA, Matsen ME, et al. Leptin activates a novel CNS mechanism for insulin-independent normalization of severe diabetic hyperglycemia. Endocrinology. 2011;152(2):394–404. https://doi.org/10.1210/en.2010-0890.CrossRefPubMed

52.

Haque MS, Minokoshi Y, Hamai M, Iwai M, Horiuchi M, Shimazu T. Role of the sympathetic nervous system and insulin in enhancing glucose uptake in peripheral tissues after intrahypothalamic injection of leptin in rats. Diabetes. 1999;48(9):1706–12. https://doi.org/10.2337/diabetes.48.9.1706.CrossRefPubMed

53.

German J, Kim F, Schwartz GJ, Havel PJ, Rhodes CJ, Schwartz MW, et al. Hypothalamic leptin signaling regulates hepatic insulin sensitivity via a neurocircuit involving the vagus nerve. Endocrinology. 2009;150(10):4502–11. https://doi.org/10.1210/en.2009-0445.CrossRefPubMedPubMedCentral

54.

•• da Silva AA, Hall JE, Moak SP, Browning J, Houghton HJ, Micheloni GC, et al. Role of autonomic nervous system in chronic CNS-mediated antidiabetic action of leptin. Am J Physiol Endocrinol Metab. 2017;312(5):E420–E8. https://doi.org/10.1152/ajpendo.00301.2016. This study demonstrates that leptin's powerful chronic CNS-mediated antidiabetic actions are independent of leptin's ability to modulate autonomic nervous system activity and suggest that a circulating factor may contribute importantly to the effects of leptin on glucose homeostasis in the absence of insulin actions.

55.

Raskin P, Unger RH. Hyperglucagonemia and its suppression. Importance in the metabolic control of diabetes. N Engl J Med. 1978;299(9):433–6. https://doi.org/10.1056/NEJM197808312990901.CrossRefPubMed

56.

Lee Y, Wang MY, Du XQ, Charron MJ, Unger RH. Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice. Diabetes. 2011;60(2):391–7. https://doi.org/10.2337/db10-0426.CrossRefPubMedPubMedCentral

57.

German JP, Wisse BE, Thaler JP, Oh IS, Sarruf DA, Ogimoto K, et al. Leptin deficiency causes insulin resistance induced by uncontrolled diabetes. Diabetes. 2010;59(7):1626–34. https://doi.org/10.2337/db09-1918.CrossRefPubMedPubMedCentral

58.

Meek TH, Dorfman MD, Matsen ME, Fischer JD, Cubelo A, Kumar MR, et al. Evidence that in uncontrolled diabetes, hyperglucagonemia is required for ketosis but not for increased hepatic glucose production or hyperglycemia. Diabetes. 2015;64(7):2376–87. https://doi.org/10.2337/db14-1562.CrossRefPubMedPubMedCentral

59.

Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, et al. Role of leptin in the neuroendocrine response to fasting. Nature. 1996;382(6588):250–2. https://doi.org/10.1038/382250a0.CrossRefPubMed

60.

Perry RJ, Zhang XM, Zhang D, Kumashiro N, Camporez JP, Cline GW, et al. Leptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis. Nat Med. 2014;20(7):759–63. https://doi.org/10.1038/nm.3579.CrossRefPubMedPubMedCentral

61.

da Silva AA, Hall JE, do Carmo JM. Leptin reverses hyperglycemia and hyperphagia in insulin deficient diabetic rats by pituitary-independent central nervous system actions. PLoS One. 2017;12(11):e0184805. https://doi.org/10.1371/journal.pone.0184805.CrossRefPubMedPubMedCentral

62.

Morton GJ, Meek TH, Matsen ME, Schwartz MW. Evidence against hypothalamic-pituitary-adrenal axis suppression in the antidiabetic action of leptin. J Clin Invest. 2015;125(12):4587–91. https://doi.org/10.1172/JCI82723.CrossRefPubMedPubMedCentral

63.

Meek TH, Morton GJ. The role of leptin in diabetes: metabolic effects. Diabetologia. 2016;59(5):928–32. https://doi.org/10.1007/s00125-016-3898-3.CrossRefPubMed

Titel: CNS Regulation of Glucose Homeostasis: Role of the Leptin-Melanocortin System
verfasst von: Alexandre A. da Silva
Jussara M. do Carmo
John E. Hall
Publikationsdatum: 01.07.2020
Verlag: Springer US
Erschienen in: Current Diabetes Reports / Ausgabe 7/2020
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI: https://doi.org/10.1007/s11892-020-01311-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2020

Gastrointestinal Peptides as Therapeutic Targets to Mitigate Obesity and Metabolic Syndrome

Euglycemic Ketoacidosis

Managing Diabetes in Hard to Reach Populations: A Review of Telehealth Interventions

Updates on Gene Therapy for Diabetic Retinopathy

Economic Simulation Modeling in Type 2 Diabetes